Overview of Comments Received on 'ICH Reflection Paper on Proposed ICH Guideline Work to Advance Patient Focused Drug Development’

On 14 April 2021 the EMA announced the availability of the overview of comments.

17 interested parties (organizations or individuals) commented on the draft document as released for consultation. The overview consists of general comments and specific comments on text. Comments will be sent to the ICH for consideration in the context of the ICH process.

Read the pdf 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /